MV Mateos
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Transplantation top 10%
Papers in
- Hematology 36
- Multiple Myeloma Research and Treatments 31
- Hematopoietic Stem Cell Transplantation 5
- Oncology 21
- Cancer Treatment and Pharmacology 8
- Peptidase Inhibition and Analysis 6
- Co-authors
- Jesús F. San Miguel (27 shared papers)María‐Belén Vídriales (5 shared papers)Marcos González (4 shared papers)José Antonio Pérez‐Simón (3 shared papers)Dolores Caballero (3 shared papers)Jesús María Hernández‐Rivas (2 shared papers)Lourdes Vázquez (2 shared papers)Berta Valverde (1 shared paper)
- Journals
- HemaSphere (6 papers)Leukemia (6 papers)Bone Marrow Transplantation (4 papers)Annals of Oncology (4 papers)Haematologica (2 papers)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
MV Mateos
39 papers receiving 881 citations
Peers
Comparison fields: 5 of 59
- Hematology 750
- Transplantation 29
- Genetics 111
- Oncology 272
- Immunology 170
Countries citing papers authored by MV Mateos
This map shows the geographic impact of MV Mateos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by MV Mateos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites MV Mateos more than expected).
Fields of papers citing papers by MV Mateos
This network shows the impact of papers produced by MV Mateos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by MV Mateos. The network helps show where MV Mateos may publish in the future.
Co-authors
The 25 scholars most cited alongside MV Mateos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 140 | |
| 2 | 2012 | 130 | |
| 3 | 2002 | 89 | |
| 4 | 2014 | 84 | |
| 5 | 2003 | 68 | |
| 6 | 1999 | 63 | |
| 7 | 2011 | 57 | |
| 8 | 2012 | 56 | |
| 9 | 2015 | 50 | |
| 10 | 2007 | 41 | |
| 11 | 2003 | 17 | |
| 12 | 2017 | 17 | |
| 13 | 2001 | 14 | |
| 14 | 2012 | 13 | |
| 15 | Prolonged therapy with bortezomib plus melphalan-prednisone (vmp) results in improved quality and duration of response in the phase iii vista study in previously untreated multiple myeloma (mm) | 2008 | 7 |
| 16 | 2009 | 6 | |
| 17 | 2017 | 6 | |
| 18 | 2017 | 5 | |
| 19 | 2013 | 5 | |
| 20 | 2009 | 5 |
About MV Mateos
MV Mateos is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 39 papers that have together received 900 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (31 papers), Protein Degradation and Inhibitors (11 papers), Cancer Treatment and Pharmacology (8 papers), Peptidase Inhibition and Analysis (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). The work is most often cited by research in Hematology (750 citations), Transplantation (29 citations), Genetics (111 citations), Oncology (272 citations) and Immunology (170 citations). MV Mateos has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Jesús F. San Miguel, María‐Belén Vídriales, Marcos González, José Antonio Pérez‐Simón, Dolores Caballero, Jesús María Hernández‐Rivas, Lourdes Vázquez, Berta Valverde, Mauricio Ocqueteau and Juana Ciudad. Their work appears in journals such as HemaSphere, Leukemia, Bone Marrow Transplantation, Annals of Oncology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.